RIVN vs SABSW · rev $1.66B vs P/E 0.0
Rivian Automotive Inc (RIVN) versus SAB Biotherapeutics Inc (SABSW) — a side-by-side from cached financials, not a winner call.
Rivian Automotive Inc (RIVN) is a auto manufacturers company listed on NASDAQ. It is led by Robert Joseph Scaringe Ph.D..
SAB Biotherapeutics Inc (SABSW) common stock listed on NASDAQ.
Latest reported RIVN revenue for 2026-06-30 was $1.66B. Net income was -$833.0M. Revenue was up 20.1% from 2026-03-31 to 2026-06-30. RIVN currently screens at market cap $21.81B.
SABSW does not have a complete income-statement cache yet.
RIVN currently screens at market cap $21.81B. SABSW currently screens at market cap $0 and trailing P/E 0.0.
Not investment advice. Open the RIVN and SABSW stock pages for the full models.
Not investment advice.